ENGIE : The decline remains the most likely outcome below the resistance
Entry price | Target | Stop-loss | Potential |
---|
€14.59 |
€13.6 |
€14.9 |
+6.79% |
---|
The zone, in which the stock price is currently trading and which forms a technical resistance, paves the way for a pullback of the stock over the coming trading sessions towards 14.42 EUR.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company is one of the best yield companies with high dividend expectations.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The stock is in a well-established, long-term rising trend above the technical support level at 13.66 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 15.03.
● Technically, the stock approaches a strong medium-term resistance at EUR 15.12.
● The company does not generate enough profits, which is an alarming weak point.
● The company is in debt and has limited leeway for investment
● The company's earnings releases usually do not meet expectations.
● Revenue estimates are regularly revised downwards for the current and coming years.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.